Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrandrine for herpes zoster-associated pain
ChiCTR2500112471Phase 4Not yet recruiting
- Sponsor
- China-Japan Friendship Hospital
- Start
- Nov 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tetrandrine in herpes zoster (HZ) (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Change in pain intensity (VAS). Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tetrandrine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2500112471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112471.